| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) through any online brokerage.
Other companies in Rhythm Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Rhythm Pharmaceuticals has a consensus price target of $131.37.
The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $92.83 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
